Cite
HARVARD Citation
Reda, G. et al. (2016). Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations. Expert opinion on drug safety. 15 (6), pp. 865-873. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reda, G. et al. (2016). Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations. Expert opinion on drug safety. 15 (6), pp. 865-873. [Online].